ガドテリドール中間体及びこれを利用したガドテリドール製造方法

Title:

ガドテリドール中間体及びこれを利用したガドテリドール製造方法

Document Type and Number:

Japanese Patent JP7032550

Kind Code:

B2

Abstract:

Disclosed are an intermediate for gadoteridol used as an MRI contrast agent, and a method for preparing gadoteridol using same. Provided, as a gadoteridol intermediate, is 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane, which is represented by chemical formula 1 in the description, or a hydrochloride thereof, which is represented by chemical formula 3 in the description.

More Like This:

JP2004506026	Perfluoroalkyl-containing complex having a polar group, its production method and its use
WO/2010/147666	COMPOUNDS USEFUL AS CARBONIC ANHYDRASE MODULATORS AND USES THEREOF
JP5475454	Metal chelates with superfluorinated PEG groups, their formulation methods, and their use

Inventors:

Lee Jae Young
Lee Jong Soo
Byeong-kyu
Lee Byung Woo
Isano
Yun Tae Myung
Bang Jehun
Song Kiyoung

Application Number:

JP2020539756A

Publication Date:

March 08, 2022

Filing Date:

January 11, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Engie Chem Life Sciences Corporation

International Classes:

C07D257/02

Domestic Patent References:

JP7507067A
JP6228115A
JP2002508755A
JP3471836B2

Foreign References:

CN106543094A

Attorney, Agent or Firm:

Kenjiro Yamaguchi
Kenichi Morita

Previous Patent: Sensitive or radiation sensitive resin compositions, sensitive or radiation sensitive films, pattern...

Next Patent: Spacer for insulating glazing, with an integrated electrical supply line in the hollow chamber